This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
5 Oct 2011

Takeda Completes Acquisition of Nycomed

Osaka-based Takeda hopes the addition of the Swiss firm will boost Takeda's sales by approximately 30% and move the company to 12th in the pharmaceutical sales table.

Japan-based Takeda Pharmaceutical has completed its acquisition of Switzerland’s Nycomed for €9.6bn ($12.67bn).

 

The addition of the Swiss firm is expected to boost Takeda's sales by approximately 30%, moving the company to 12th in the pharmaceutical sales table.

 

"The combination of both organisations will enable us to sustain medium and long term growth targets starting in fiscal 2015 and extending into the next decade", said Takeda chief executive Yasuchika Hasegawa.

 

Under the acquisition deal, Frank Morich will be appointed as Nycomed chief executive, with existing chief executive Hakan Bjorklund to remain a "strategic advisor" upon his retirement from the company.

 

Related News